99 related articles for article (PubMed ID: 8769209)
1. Interim analysis of study OLN-356: Neoral versus Sandimmune in US primary liver transplant recipients. OLN-356 Principal Investigators.
Pinson CW; Beauregard-Zollinger L
Transplant Proc; 1996 Aug; 28(4):2234-6. PubMed ID: 8769209
[No Abstract] [Full Text] [Related]
2. Conversion from Sandimmune to Neoral in stable renal transplant recipients. Sandoz Study Group OLN-353.
Pescovitz MD
Transplant Proc; 1996 Aug; 28(4):2196-8. PubMed ID: 8769198
[No Abstract] [Full Text] [Related]
3. Comparison of the long-term tolerability, pharmacodynamics, and safety of Sandimmune and Neoral in liver transplant recipients. Ontario Liver Transplant Study Group.
Grant D; Rochon J; Levy G
Transplant Proc; 1996 Aug; 28(4):2232-3. PubMed ID: 8769208
[No Abstract] [Full Text] [Related]
4. Case study: conversion of a liver transplant patient from cyclosporine Sandimmune to Neoral.
Levy GA
Transplant Proc; 1996 Aug; 28(4):2252-3. PubMed ID: 8769216
[No Abstract] [Full Text] [Related]
5. Conversion from Sandimmune to Neoral in stable liver graft recipients.
Pollard SG; Lodge JP
Transplant Proc; 1996 Aug; 28(4):2244-6. PubMed ID: 8769213
[No Abstract] [Full Text] [Related]
6. An open randomized parallel group study to compare Sandimmune Neoral with Sandimmune soft gelatin capsule in stable renal transplant patients.
Park K; Koh YB; Kwak JY; Kim SJ; Yoon YS; Kang CM; Kim YS
Transplant Proc; 1996 Jun; 28(3):1202-3. PubMed ID: 8658627
[No Abstract] [Full Text] [Related]
7. Changing stable heart transplant recipients from Sandimmune to Neoral.
Dalrymple-Hay M; Meara M; Reynolds L; Backhouse L; Wright D; Holt D; Johnston A; Madden B; Murday A
Transplant Proc; 1996 Aug; 28(4):2285-6. PubMed ID: 8769227
[No Abstract] [Full Text] [Related]
8. Safety and tolerability of Neoral in transplant recipients.
Feutren G; Wong R; Jin J; Niese D; Mellein B
Transplant Proc; 1996 Aug; 28(4):2177-82. PubMed ID: 8769193
[No Abstract] [Full Text] [Related]
9. Conversion from Sandimmune to Neoral in stable heart transplant recipients.
Pethig K; Ruhparwar A; Korn A; Christians U; Wahlers T
Transplant Proc; 1996 Aug; 28(4):2287-9. PubMed ID: 8769228
[No Abstract] [Full Text] [Related]
10. Change of conventional cyclosporine to neoral cyclosporine formulation in long-term liver transplant recipients.
Diliz HS; Olivera MA; Kershenobich D; Mercado MA; Orozco H
Transplant Proc; 1996 Dec; 28(6):3348-50. PubMed ID: 8962302
[No Abstract] [Full Text] [Related]
11. Conversion from cyclosporine to Neoral in pediatric recipients for kidney, liver, and heart transplantation.
Holmberg C; Laine J; Jalanko H; Leijala M; Hoppu K
Transplant Proc; 1996 Aug; 28(4):2262-3. PubMed ID: 8769219
[No Abstract] [Full Text] [Related]
12. Successful reconversion from tacrolimus to cyclosporine A Neoral in pediatric liver recipients.
Melter M; Rodeck B; Kardorff R; Hoyer PF; Maibücher A; Brodehl J
Transplant Proc; 1996 Aug; 28(4):2276-8. PubMed ID: 8769224
[No Abstract] [Full Text] [Related]
13. Neoral in liver transplantation.
Jamieson NV; Tan L; Jamieson I; Trull A; Gimson AE; Alexander G; Friend PJ; Calne RY
Transplant Proc; 1996 Aug; 28(4):2229-31. PubMed ID: 8769207
[No Abstract] [Full Text] [Related]
14. Absorption of cyclosporine Neoral early after liver transplantation: is it possible to abandon intravenous cyclosporine A application?
Haller GW; Winkler M; Bechstein WO; Oldhafer KJ; Ringe B; Maibücher A; Färber L; Pichlmayr R; Neuhaus P
Transplant Proc; 1996 Aug; 28(4):2239-40. PubMed ID: 8769211
[No Abstract] [Full Text] [Related]
15. Potential role of Neoral in pediatric liver transplantation.
Whitington PF; Alonso EM; Millis JM
Transplant Proc; 1996 Aug; 28(4):2267-9. PubMed ID: 8769221
[No Abstract] [Full Text] [Related]
16. Conversion from Sandimmune to Neoral in stable renal and pancreas transplant recipients enhances cyclosporine absorption.
Chapman JR; O'Connell PJ; Bovington KJ; Allen RD
Transplant Proc; 1996 Aug; 28(4):2293-5. PubMed ID: 8769229
[No Abstract] [Full Text] [Related]
17. Pharmacokinetics of a microemulsion formulation of cyclosporine in pediatric liver transplant recipients.
Cooney GF; Lum BL; Meligeni JA; Dunn SP
Transplant Proc; 1996 Aug; 28(4):2270-2. PubMed ID: 8769222
[No Abstract] [Full Text] [Related]
18. A randomized, controlled trial to assess the safety of switching stable renal transplant patients from Sandimmun to Sandimmun Neoral.
Loo CS; Morad Z; Lim TO; Fan KS; Suleiman AB
Transplant Proc; 1996 Jun; 28(3):1328-9. PubMed ID: 8658680
[No Abstract] [Full Text] [Related]
19. Pharmacokinetic, hemodynamic, and metabolic effects of cyclosporine sandimmune versus the microemulsion neoral in heart transplant recipients.
White M; Pelletier GB; Tan A; Jesina C; Carrier M
J Heart Lung Transplant; 1997 Aug; 16(8):787-94. PubMed ID: 9286770
[TBL] [Abstract][Full Text] [Related]
20. Absorption of cyclosporine Neoral early after liver transplantation: influence of bile on oral absorption.
Oldhafer K; Haller GW; Kattner A; Winkler M; Maibücher A; Färber L; Bechstein WO; Ringe B; Neuhaus P; Pichlmayr R
Transplant Proc; 1996 Aug; 28(4):2237-8. PubMed ID: 8769210
[No Abstract] [Full Text] [Related]
[Next] [New Search]
